help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Simard, J.
Right arrow Articles by Labrie, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Simard, J.
Right arrow Articles by Labrie, F.

Endocrinology, Vol 126, 3223-3231, Copyright © 1990 by Endocrine Society


ARTICLES

Regulation of progesterone-binding breast cyst protein GCDFP-24 secretion by estrogens and androgens in human breast cancer cells: a new marker of steroid action in breast cancer

J Simard, S Dauvois, DE Haagensen, C Levesque, Y Merand and F Labrie
Medical Research Council Group in Molecular Endocrinology, CHUL Research Center, Quebec, Canada.

We have previously demonstrated that androgens are potent inhibitors of breast cancer cell proliferation under both basal and estrogen-induced incubation conditions, while they suppress expression of the estrogen and progesterone receptors. To better understand the mechanisms responsible for the antagonism between androgens and estrogens in breast cancer and to obtain a new tumor marker for the actions of these two steroids, we have investigated the effects of androgens and estrogens on expression of the major protein found in human breast gross cystic disease fluid, namely GCDFP-24. This study was performed in ZR-75-1 and MCF-7 human breast cancer cells. After a 9-day incubation period, physiological concentrations of 17 beta-estradiol stimulated proliferation of ZR-75-1 and MCF-7 cells by 2- to 3.5-fold while simultaneously exerting a marked 70-90% inhibition of GCDFP-24 secretion. The estrogenic effects on GCDFP-24 secretion and cell proliferation were both competitively blocked by simultaneous incubation with the new steroidal pure antiestrogen EM-139. On the other hand, a maximal concentration (10 nM) of the nonaromatizable androgen dihydrotestosterone decreased by 50% the proliferation of ZR- 75-1 cells; the half-maximal inhibitory effect was exerted at 0.01 nM. The androgen exerted a 3- to 4-fold stimulatory effect on GCDFP-24 secretion at an EC50 value of 0.01 nM. The effect of dihydrotestosterone on these parameters was competitively blocked by simultaneous incubation with the pure antiandrogen OH-flutamide. The present data show that the effects of estrogens and androgens in ZR-75- 1 cells on GCDFP-24 secretion and cell growth are opposite. Similarly, in MCF-7 cells, estrogens stimulate cell growth, while GCDFP-24 secretion is inhibited. The present data also suggest that GCDFP-24 could well be a good biochemical marker for monitoring the response to androgenic and antiestrogenic compounds in the therapy of advanced breast cancer.


This article has been cited by other articles:


Home page
Endocr Relat CancerHome page
F Labrie
Future perspectives of selective estrogen receptor modulators used alone and in combination with DHEA.
Endocr. Relat. Cancer, June 1, 2006; 13(2): 335 - 355.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
F. Gizard, R. Robillard, O. Barbier, B. Quatannens, A. Faucompre, F. Revillion, J.-P. Peyrat, B. Staels, and D. W. Hum
TReP-132 Controls Cell Proliferation by Regulating the Expression of the Cyclin-Dependent Kinase Inhibitors p21WAF1/Cip1 and p27Kip1
Mol. Cell. Biol., June 1, 2005; 25(11): 4335 - 4348.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
F. Labrie, V. Luu-The, C. Labrie, A. Belanger, J. Simard, S.-X. Lin, and G. Pelletier
Endocrine and Intracrine Sources of Androgens in Women: Inhibition of Breast Cancer and Other Roles of Androgens and Their Precursor Dehydroepiandrosterone
Endocr. Rev., April 1, 2003; 24(2): 152 - 182.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
J. Lapointe and C. Labrie
Role of the Cyclin-Dependent Kinase Inhibitor p27Kip1 in Androgen-Induced Inhibition of CAMA-1 Breast Cancer Cell Proliferation
Endocrinology, October 1, 2001; 142(10): 4331 - 4338.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
D. F. Hargreaves, C. S. Potten, C. Harding, L. E. Shaw, M. S. Morton, S. A. Roberts, A. Howell, and N. J. Bundred
Two-Week Dietary Soy Supplementation Has an Estrogenic Effect on Normal Premenopausal Breast
J. Clin. Endocrinol. Metab., November 1, 1999; 84(11): 4017 - 4024.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
J. Lapointe and C. Labrie
Identification and Cloning of a Novel Androgen-Responsive Gene, Uridine Diphosphoglucose Dehydrogenase, in Human Breast Cancer Cells
Endocrinology, October 1, 1999; 140(10): 4486 - 4493.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
J. Lapointe, A. Fournier, V. Richard, and C. Labrie
Androgens Down-Regulate bcl-2 Protooncogene Expression in ZR-75-1 Human Breast Cancer Cells
Endocrinology, January 1, 1999; 140(1): 416 - 421.
[Abstract] [Full Text]


Home page
Endocr. Rev.Home page
C. Lopez-Otin and E. P. Diamandis
Breast and Prostate Cancer: An Analysis of Common Epidemiological, Genetic, and Biochemical Features
Endocr. Rev., August 1, 1998; 19(4): 365 - 396.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
C. Martel, C. Labrie, A. Belanger, S. Gauthier, Y. Merand, X. Li, L. Provencher, B. Candas, and F. Labrie
Comparison of the Effects of the New Orally Active Antiestrogen EM-800 with ICI 182 780 and Toremifene on Estrogen-Sensitive Parameters in the Ovariectomized Mouse
Endocrinology, May 1, 1998; 139(5): 2486 - 2492.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
S. Luo, A. Sourla, C. Labrie, S. Gauthier, Y. Merand, A. Belanger, and F. Labrie
Effect of Twenty-Four-Week Treatment with the Antiestrogen EM-800 on Estrogen-Sensitive Parameters in Intact and Ovariectomized Mice
Endocrinology, May 1, 1998; 139(5): 2645 - 2656.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. S. Lopez-Boado, M. Klaus, M. I. Dawson, and C. Lopez-Otin
Retinoic Acid-induced Expression of Apolipoprotein D and Concomitant Growth Arrest in Human Breast Cancer Cells Are Mediated through a Retinoic Acid Receptor RARalpha -dependent Signaling Pathway
J. Biol. Chem., December 13, 1996; 271(50): 32105 - 32111.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Huber, J. G. Pelletier, K. Torossian, P. Dionne, I. Gamache, R. Charest-Gaudreault, M. Audette, and R. Poulin
2,2'-Dithiobis(N-ethyl-spermine-5-carboxamide) Is a High Affinity, Membrane-impermeant Antagonist of the Mammalian Polyamine Transport System
J. Biol. Chem., November 1, 1996; 271(44): 27556 - 27563.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Lessard, C. Zhao, S. M. Singh, and R. Poulin
Hormonal and Feedback Regulation of Putrescine and Spermidine Transport in Human Breast Cancer Cells
J. Biol. Chem., January 27, 1995; 270(4): 1685 - 1694.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Poulin, M. Lessard, and C. Zhao
Inorganic Cation Dependence of Putrescine and Spermidine Transport in Human Breast Cancer Cells
J. Biol. Chem., January 27, 1995; 270(4): 1695 - 1704.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1990 by The Endocrine Society